A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

NCT00219193 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
641
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis